The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma.

MLA

Xu-Dong Qu, et al. “The Efficacy of TACE Combined Sorafenib in Advanced Stages Hepatocellullar Carcinoma.” BMC Cancer, vol. 12, no. 1, Jan. 2012, pp. 263–68. EBSCOhost, https://doi.org/10.1186/1471-2407-12-263.

APA

Xu-Dong Qu, Cheng-Shi Chen, Jian-Hua Wang, hi-ping Yan, Jie-min Chen, Gao-quan Gong, Qin-xin Liu, Jian-jun Luo, Lin-xiao Liu, Rong Liu, & Sheng Qian. (2012). The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma. BMC Cancer, 12(1), 263–268. https://doi.org/10.1186/1471-2407-12-263

Chicago

Xu-Dong Qu, Cheng-Shi Chen, Jian-Hua Wang, hi-ping Yan, Jie-min Chen, Gao-quan Gong, Qin-xin Liu, et al. 2012. “The Efficacy of TACE Combined Sorafenib in Advanced Stages Hepatocellullar Carcinoma.” BMC Cancer 12 (1): 263–68. doi:10.1186/1471-2407-12-263.